- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/32 - Alcohol-abuse
Patent holdings for IPC class A61P 25/32
Total number of patents in this class: 538
10-year publication summary
|
16
|
34
|
43
|
41
|
34
|
37
|
42
|
31
|
40
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2722 |
12 |
| H. Lundbeck A/S | 1246 |
10 |
| The Regents of the University of California | 20447 |
9 |
| Clearmind Labs Corp. | 14 |
9 |
| Hoffmann-La Roche Inc. | 3640 |
6 |
| The Regents of the University of Colorado, a body corporate | 2768 |
6 |
| Texas Tech University System | 625 |
6 |
| Sophrosyne Pharmaceuticals Limited | 8 |
6 |
| Purdue Research Foundation | 3805 |
5 |
| Daiichi Sankyo Company, Limited | 1880 |
5 |
| Mitsubishi Tanabe Pharma Corporation | 535 |
5 |
| Purdue Pharma L.P. | 495 |
5 |
| Board of Regents, The University of Texas System | 6028 |
4 |
| Aegis Therapeutics, LLC | 55 |
4 |
| Arena Pharmaceuticals, Inc. | 361 |
4 |
| Biohit Oyj | 50 |
4 |
| Indivior UK Limited | 193 |
4 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3102 |
4 |
| Laboratorio Farmaceutico C.T. S.r.l. | 20 |
4 |
| Metabomed Ltd. | 10 |
4 |
| Other owners | 422 |